Tactile Systems Technology Inc $TCMD
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Minneapolis, MN
- Fiscal year end
- December 31
- Shares outstanding
- 22,652,286 [10-Q 2026-08-10]
What the company doesAI summary of filing
Tactile Systems Technology develops and sells medical devices for at-home treatment of chronic diseases, primarily lymphedema, chronic venous insufficiency, and chronic respiratory conditions. The company generates revenue through two distribution models: a direct-to-patient and -provider model for lymphedema products (Flexitouch Plus, Entre Plus, and Nimbl systems) and a durable medical equipment distributor model for its respiratory product (AffloVest). For the year ended December 31, 2025, the company generated $329.5 million in revenue with net income of $19.1 million, representing a 12% increase in revenue compared to the prior year. [10-K 2026-02-17]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $160.97M | $6.02M | $2.92M | $69.85M | [10-Q 2026-08-10] |
| FY ended Dec 2025 | $329.52M | $19.09M | $42.81M | $83.45M | [10-K 2026-02-17] |
| FY ended Dec 2024 | $292.98M | $16.96M | $40.66M | $94.37M | [10-K 2026-02-17] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 23,997,089 | [10-Q 2024-11-04] |
| 2025-02-14 | 23,585,175 | [10-K 2025-02-18] |
| 2025-05-01 | 23,248,353 | [10-Q 2025-05-05] |
| 2025-07-31 | 22,292,145 | [10-Q 2025-08-04] |
| 2025-10-30 | 22,335,582 | [10-Q 2025-11-03] |
| 2026-02-13 | 22,438,926 | [10-K 2026-02-17] |
| 2026-04-30 | 22,556,260 | [10-Q 2026-05-04] |
| 2026-08-06 | 22,652,286 | [10-Q 2026-08-10] |
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-10 | Dodd Sheri Louise | sell | 10,978 | $29.44 | [4 2026-08-12] |
| 2026-05-11 | Birkemeyer Elaine M. | sell | 4,631 | $24.49 | [4 2026-05-13] |
| 2026-05-06 | Asbury Valerie L. | grant | 6,521 | — | [4 2026-05-08] |
| 2026-05-06 | Huggenberger Raymond | grant | 6,521 | — | [4 2026-05-08] |
| 2026-05-06 | King Laura G. | grant | 6,521 | — | [4 2026-05-08] |
| 2026-05-06 | Pearson Andrea | grant | 6,521 | — | [4 2026-05-08] |
| 2026-05-06 | Shafer David Brent | grant | 6,521 | — | [4 2026-05-08] |
| 2026-05-06 | Volkart Carmen B | grant | 6,521 | — | [4 2026-05-08] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-12 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-10 | 10-Q | Quarterly report |
| 2026-08-10 | 8-K | Results of operations |
| 2026-07-13 | 8-K | Regulation FD disclosure; Other events |
| 2026-05-07 | 8-K | Charter, bylaws or fiscal year change; Shareholder vote results |
| 2026-05-04 | 10-Q | Quarterly report |
| 2026-05-04 | 8-K | Results of operations |
| 2026-03-27 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-03-25 | DEF 14A | Proxy statement |
| 2026-03-10 | PRE 14A | Proxy statement |
| 2026-03-09 | 8-K | Director or officer change; Regulation FD disclosure |
Alerts for $TCMD
Email me when Tactile Systems Technology Inc files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.